FDA Approves Supplement for Gadobutrol by Hengrui Pharma
The FDA has approved a supplemental application for Gadobutrol submitted by Hengrui Pharma.
Company
Pharmaceutical intelligence for Hengrui Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
The FDA has approved a supplemental application for Gadobutrol submitted by Hengrui Pharma.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.